Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Nippon Shokubai invests in APIs

by Jean-François Tremblay
October 9, 2017 | A version of this story appeared in Volume 95, Issue 40

Nippon Shokubai is entering the business of producing active pharmaceutical ingredients (APIs) for peptide and nucleic acid drugs. The company will build a plant in Suita, Japan, where it opened an API synthesis lab last year. The facility will be able to produce APIs in quantities ranging from milligrams to kilograms. Nippon Shokubai, best known as the world’s largest producer of superabsorbent polymers used in diapers and sanitary pads, has a strategy to expand in the medical field over the next three years.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.